Literature DB >> 9460713

Expression of myogenic regulatory factors (MRFs) in human neuromuscular disorders.

M Olivé1, J A Martinez-Matos, P Pirretas, M Povedano, C Navarro, I Ferrer.   

Abstract

Immunohistochemical studies using antibodies to myogenic regulatory factors (MRFs) Myo D, myogenin, myf-5, and myf-6, and transcription factors c-Fos and c-Jun, were performed on muscle biopsies from patients suffering from Duchenne and Becker muscular dystrophies, polymyositis, and denervation atrophy, to investigate whether expression of these factors occurs during degeneration and regeneration of adult muscle fibres. Strong Myo D, myogenin, myf-5 and myf-6 immunoreactivity was observed in the nuclei of small regenerating fibres and satellite cells, as revealed by double-labelling immunohistochemistry with N-CAM antibodies, in Duchenne and Becker muscular dystrophies and in polymyositis. This suggests that the myogenic programme is activated during regeneration of adult human muscle fibres. In addition, strong myf-6 and c-Jun immunoreactivity was found in the cytoplasm of some necrotic muscle fibres in patients with Duchenne and Becker muscular dystrophies and in patients with polymyositis. The latter findings suggest that strong cytoplasmic expression of myf-6 and c-Jun is related to the process of muscle fibre degeneration that occurs in these conditions. Increased Myo D, myogenin, myf-5 and myf-6 immunoreactivity was not observed in the nuclei of denervated muscle fibres, although strong c-Fos and c-Jun immunoreactivity was seen in the nuclei of denervated muscle fibres; this suggests that denervation triggers the expression of these transcription factors. Taken together, these observations demonstrate that MRFs and c-Fos and c-Jun are selectively expressed in different human muscular disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9460713     DOI: 10.1111/j.1365-2990.1997.tb01324.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  5 in total

1.  Myogenic differentiation factor 1 and myogenin expression not elevated in regenerated masticatory muscles of dystrophic (mdx) mice.

Authors:  Alexander Spassov; Tomasz Gredes; Christian Lehmann; Tomasz Gedrange; Silke Lucke; Dragan Pavlovic; Christiane Kunert-Keil
Journal:  J Orofac Orthop       Date:  2011-11-30       Impact factor: 1.938

2.  Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.

Authors:  Anna Vihola; Linda L Bachinski; Mario Sirito; Shodimu-Emmanuel Olufemi; Shohrae Hajibashi; Keith A Baggerly; Olayinka Raheem; Hannu Haapasalo; Tiina Suominen; Jeanette Holmlund-Hampf; Anders Paetau; Rosanna Cardani; Giovanni Meola; Hannu Kalimo; Lars Edström; Ralf Krahe; Bjarne Udd
Journal:  Acta Neuropathol       Date:  2010-01-12       Impact factor: 17.088

3.  Acupuncture plus low-frequency electrical stimulation (Acu-LFES) attenuates denervation-induced muscle atrophy.

Authors:  Zhen Su; Li Hu; Jinzhong Cheng; Janet D Klein; Faten Hassounah; Hui Cai; Min Li; Haidong Wang; Xiaonan H Wang
Journal:  J Appl Physiol (1985)       Date:  2015-12-17

4.  IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men.

Authors:  Brooke C Harrison; David L Allen; Leslie A Leinwand
Journal:  Skelet Muscle       Date:  2011-02-01       Impact factor: 4.912

5.  Gene expression profiling in limb-girdle muscular dystrophy 2A.

Authors:  Amets Sáenz; Margarita Azpitarte; Rubén Armañanzas; France Leturcq; Ainhoa Alzualde; Iñaki Inza; Federico García-Bragado; Gaspar De la Herran; Julián Corcuera; Ana Cabello; Carmen Navarro; Carolina De la Torre; Eduard Gallardo; Isabel Illa; Adolfo López de Munain
Journal:  PLoS One       Date:  2008-11-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.